Psoriasis: Scratching The Surface

Date: Oct-16-2012Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population.

A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.

In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 might be a useful therapeutic target in the treatment of psoriasis.

TITLE:
Psoriasiform dermatitis is driven by interleukin-36-mediated dendritic cell-keratinocyte crosstalk

View this article at: http://www.jci.org/articles/view/63451?key=94c50375c771888cd255

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.